Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3476
-0.0083 (-2.33%)
At close: Oct 2, 2026, 4:00 PM EDT
0.3690
+0.0214 (6.16%)
After-hours: Oct 2, 2026, 7:56 PM EDT
Heron Therapeutics Employees
Heron Therapeutics had 128 employees as of December 31, 2025. The number of employees increased by 6 or 4.92% compared to the previous year.
Employees
128
Change (1Y)
6
Growth (1Y)
4.92%
Revenue / Employee
$1,181,078
Profits / Employee
-$266,008
Market Cap
65.99M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | 6 | 4.92% |
| Dec 31, 2024 | 122 | -4 | -3.17% |
| Dec 31, 2023 | 126 | -77 | -37.93% |
| Dec 31, 2022 | 203 | -99 | -32.78% |
| Dec 31, 2021 | 302 | 79 | 35.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Alps Group | 93 |
| XBiotech | 87 |
| MindWalk Holdings | 77 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| MiNK Therapeutics | 15 |
| Alterity Therapeutics | 11 |
HRTX News
- 3 days ago - Heron Therapeutics enters license agreement with Long Grove, Capstone - TheFly
- 7 weeks ago - Heron Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 7 weeks ago - Heron Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Heron Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Heron Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026 - GlobeNewsWire
- 3 months ago - Heron Therapeutics Transcript: AGM 2026 - Transcripts
- 4 months ago - Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright - TheFly